David Ferrera Spotlights RC Medical's Venture Studio Model for Interventional Radiology

Oct 24, 2026

David Ferrera, CEO of RC Medical, explains how the venture studio turns physician ideas into standalone device companies, and why that structure fits interventional radiology better than a traditional consulting shop.

LAKE FOREST, CA, October 24, 2026 /24-7PressRelease/ -- Most medical device companies start with an engineer's idea and go looking for a clinical problem to fit it. RC Medical starts in the opposite place.

"We go to the interventional suite first," Ferrera says. "The physicians there see the gaps every week. Our job is to listen, then build the company around what they're actually describing."

RC Medical is a medical device venture studio that funds, designs, develops, and commercializes products for the interventional radiology market. Rather than taking on contract work for outside clients, the studio partners directly with physician-entrepreneurs to identify new technology and new indications for devices, then forms a standalone company to carry each idea forward.

How the Studio Works With Physicians

A physician who brings an idea to RC Medical isn't handing it off and waiting for a report back. Ferrera describes the relationship as a partnership that runs from the first sketch through commercialization.

"A physician knows the problem better than anyone," he says. "What we bring is the engineering, the regulatory path, and the discipline to turn that problem into something that can actually reach patients. Neither side can do it alone."

That division of labor is the core of the studio model. The physician stays close to the clinical need. RC Medical manages product development, funding, and the business structure needed to commercialize it.

From Concept to Newco

When an idea clears that early bar, RC Medical doesn't fold it into an existing product line. It forms a new company around it.

"Each idea gets its own company, its own team, its own focus," Ferrera says. "A big portfolio company can lose a good idea in the shuffle. A newco can't afford to."

That approach has produced three separate companies out of the studio: Single Pass, Infinity Neuro, and Sonorous NV. Each one grew out of a specific problem a physician described in the interventional suite, and each operates as its own business rather than a product line inside RC Medical.

Why Interventional Radiology Needs This Structure

Ferrera has spent close to three decades building devices for interventional neuroradiology and related fields, including his time as a co-founder of Blockade Medical and as Chief Technology Officer of Balt Global. He says the lesson that carries over to RC Medical is simple: the physicians in these procedures see problems that never make it into a traditional product roadmap.

"A catheter that works in a textbook case can still fail in the specific anatomy a physician sees three times a week," he says. "That detail doesn't show up unless you're building with the physician, not for them."

The studio model is built to catch that detail early, before a device design is locked in and hard to change.

What Physicians Should Expect

Ferrera says the studio isn't the right fit for every idea that comes through the door, and he doesn't present it that way to the physicians who bring one in.

"Some ideas are better as a feature of an existing product, not a new company," he says. "Part of the first conversation is being honest about which one this is."

For the ideas that do become a newco, Ferrera says the physician's involvement doesn't end once the company is formed. Many stay close to the product as it moves through development and toward the market, which keeps the clinical need in view at every stage rather than only at the start.

David Ferrera is CEO of RC Medical, a medical device venture studio based in Lake Forest, California, that funds, designs, develops, and commercializes products for the interventional radiology market. He has nearly 30 years of experience in the medical device field, including roles as Chief Technology Officer of Balt Global and co-founder of Blockade Medical, which was acquired by Balt Extrusion in 2016. He is the author of "Innovation in Translation: How Big Ideas Really Happen," published by Forbes Books in 2021.

Read the original story here: https://www.24-7pressrelease.com/press-release/539873/david-ferrera-spotlights-rc-medicals-venture-studio-model-for-interventional-radiology

Press Release Service and Press Release Distribution by 24-7 Press Release Newswire